<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1510246052
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        MOMATE NASAL SPRAY
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        MOMETASONE FUROATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Nasal use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Spray
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        120
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Nasal Applicator
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        22.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Glenmark Pharmaceuticals Limited - Baddi" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Glenmark Pharmaceuticals Limited - Baddi
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Glenmark Pharmaceuticals Limited
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R01AD09 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Momate Nasal Spray contains mometasone furoate, one of a group of medicines called Corticosteroids. Mometasone furoate should not be confused with &quot;anabolic&quot; steroids misused by some athletes and taken as tablets or injections. When tiny amounts of mometasone furoate are sprayed into the nose, it can help to relieve inflammation, sneezing, itching and a blocked up or runny nose.</p><p><u>hayfever and perennial rhinitis</u></p><p>Momate Nasal Spray is used to treat the symptoms of hay fever (also called seasonal allergic rhinitis) and perennial rhinitis in adults and children aged 3 and older.</p><p>Hay fever, which occurs at certain times of the year, is an allergic reaction caused by breathing in pollen from trees, grasses, weeds and also molds and fungal spores. Perennial rhinitis occurs throughout the year and symptoms can be caused by a sensitivity to a variety of things Including house dust mite, animal hair (or dander), feathers and certain foods. Momate Nasal Spray reduces the swelling and irritation in your nose and thereby relieving sneezing, itching and a blocked-up or runny nose caused by hay fever or perennial rhinitis.</p><p>&nbsp;</p><p><u>Nasal polyps</u></p><p>Momate Nasal Spray is used to treat nasal polyps in adults aged 18 and over.</p><p>Nasal polyps are small growths on the lining of the nose and usually affect both nostrils. Momate Nasal Spray reduces the inflammation in the nose, causing the polyps to gradually shrink, thereby relieving a blocked feeling in the nose which may affect breathing through the nose.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not use Momate Nasal Spray</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic (hypersensitive) to mometasone furoate or any of the other ingredients of Momate Nasal Spray.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have an infection in your nose. You should wait until the infection is resolved before you start using the nasal spray.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you have recently had an operation on your nose or you have injured your nose. You should not use this nasal spray until your nose has healed.</p><p>&nbsp;</p><p><strong>Warning and precautions </strong></p><p>Talk to your doctor or pharmacist before using Momate Nasal Spray if:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have or have ever had tuberculosis</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have any other type of infection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you are taking other corticosteroid medicines, either by mouth or by injection</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; you have cystic fibrosis</p><p>While using Momate Nasal Spray, talk to your doctor</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If your immune system is not functioning well(if you have difficulty in fighting infection) and you come into contact with any one with measles or chickenpox. You should avoid coming into contact with anyone who has these infections.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have an infection of the nose or throat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are using the medicine for several months or longer.</p><p>If you have persistent irritation to the nose or throat.</p><p>&nbsp;</p><p>When corticosteroid nasal sprays are used at high doses for long periods of time, side effects may occur due to the drug being absorbed in the body.</p><p>If your eyes are itching or irritated, your doctor may recommend that you use other treatments with Momate Nasal Spray.</p><p>Contact your doctor if you experience blurred vision or other visual disturbances.</p><p>&nbsp;</p><p><strong>Children</strong></p><p>When used at high doses for long periods of time, corticosteroid nasal sprays may cause certain side-effects, such as slowed growth rate in children.</p><p>It is recommended that the height of children receiving long-term treatment with nasal corticosteroids is regularly monitored and if any changes are noted, their doctor should be notified.</p><p><strong>&nbsp;</strong></p><p><strong>Other medicines and Momate Nasal Spray</strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.</p><p>If you are taking other corticosteroid medicines for allergy, either by mouth or injection, your doctor may advise you to stop taking them once you begin using Momate Nasal Spray.A few people may find that once they discontinue oral or injected corticosteroids they suffer from some undesirable effects, such as joint or muscular pain, weakness and depression. You may also seem to develop other allergies, such as itchy, watering eyes or patches of red and itchy skin. If you develop any of these effects, you should contact your doctor.</p><p>Some medicines may increase the effects of Momate Nasal Spray and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding </strong></p><p>There is little or no information on the use of Momate Nasal Spray in pregnant women. It is not known if mometasone furoate is found in breast milk.</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are &nbsp;planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>Driving and using machines</p><p>There is no known Information on the effect of Momate Nasal Spray on the ability to drive or use machinery.&nbsp;</p><p>&nbsp;</p><p><strong>Momate Nasal Spray contains benzalkonium chloride </strong>Momate Nasal Spray contains benzalkonium chloride which may cause nasal irritation.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Momate Nasal Spray exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Do not use a larger dose or use the spray more often or for longer than your doctor tells you to.</p><p><strong>Treatment of hayfever and perennial rhinitis </strong></p><p>Use in adult s and children over12 years old</p><p><strong>The usual dose is two sprays into each nostril once a day.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Once your symptoms are under control, your doctor may advise you to decrease the dose.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you do not start to feel any better, you should see your doctor and he or she may tell you to increase the dose to the maximum daily dose is four sprays into each nostril once a day.</p><p>&nbsp;</p><p><strong>Use in children aged3 to11years</strong></p><p><strong>The usual dose is one spray into each nostril once daily.</strong></p><p>In some patients Momate Nasal Spray begins to relieve symptoms within 12 hours after the first dose; however full benefit of treatment may not be seen in the first two days. Therefore, you should continue regular use to achieve full benefit of treatment.</p><p>If you or your child suffer badly from hayfever, your doctor may tell you to start using Momate Nasal Spray some days before the start of the pollen season, as this will help to prevent your hayfever symptoms from occurring.</p><p><strong>&nbsp;</strong></p><p><strong>Nasal Polyps</strong></p><p>Use in adult s over18 years old</p><p><strong>The usual starting dose is two sprays into each nostril once daily.</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If symptoms are not controlled after 5 to 6 weeks, the dose maybe increased to two sprays in each nostril twice daily. Once symptoms are under control, your doctor may advise you to decrease your dose.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If no improvement in symptoms is seen after 5 to 6 weeks of twice daily administration, you should contact your doctor.</p><p><strong>&nbsp;</strong></p><p><strong>Preparing your nasal spray for use </strong></p><p>Your Momate Nasal Spray has a dust cap which protects the nozzle and keeps it clean. Remember to take this off before using the spray and to replace it after use.</p><p>If you are using the spray for the first time you need to &#39;prime&middot; the bottle by pumping the spray10 times until a fine mist is produced:</p><p>1.Gently shake the bottle.</p><p>2.Put your forefinger and middle finger either side of the nozzle and your thumb underneath the bottle. Do Not pierce the nasal applicator.</p><p>3.Point the nozzle away from you and then press down with your fingers to pump the spray 10 times until a fine mist is produced.</p><p>If you have not used the spray for 7 days or more, you need to &quot;re-prime&quot; the bottle by pumping the spray 2 times until a fine mist is produced.</p><p><strong>How to use your nasal spray</strong></p><p>1. Shake the bottle gently and remove the dust cap. (Figure 1)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="صورة_x0020_75" o:spid="_x0000_i1027" type="#_x0000_t75"
 style='width:40.5pt;height:44.25pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image001.emz"
  o:title=""/>
</v:shape><![endif]--><img width="54" height="59" alt="" vspace="0" hspace="0" border="0" style="width:54px;height:59px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image002.gif" />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Figure1)</p><p>&nbsp;</p><p>2. Gently blow your nose.</p><p>3. Close one nostril and put the nozzle into the other nostril as shown. (Figure 2) Tilt your head forward slightly, keeping the bottle upright.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<!--[if gte vml 1]><v:shape id="صورة_x0020_76" o:spid="_x0000_i1026"
 type="#_x0000_t75" style='width:41.25pt;height:42.75pt;visibility:visible;
 mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image003.emz"
  o:title=""/>
</v:shape><![endif]--><img width="55" height="57" alt="" vspace="0" hspace="0" border="0" style="width:55px;height:57px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image004.gif" />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Figure 2)</p><p>&nbsp;</p><p>4. Start to breathe in gently or slowly through your nose and whilst you are breathing in squirt a spray of fine mist into your nose by pressing down ONCE with your fingers.</p><p>5. Breathe out through your mouth. Repeat step 4 to inhale a second spray in the same nostril.</p><p>6. Remove the nozzle from this nostril and breathe out through the mouth.</p><p>7. Repeat steps 3to6 for the other nostril. &nbsp;</p><p>After using the spray, wipe the nozzle carefully with a clean handkerchief or tissue and replace the dust cap. (Figure3).</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<!--[if gte vml 1]><v:shape id="صورة_x0020_77" o:spid="_x0000_i1025"
 type="#_x0000_t75" style='width:40.5pt;height:41.25pt;visibility:visible;
 mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image005.emz"
  o:title=""/>
</v:shape><![endif]--><img width="54" height="55" alt="" vspace="0" hspace="0" border="0" style="width:54px;height:55px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" src="file:///C:/Users/A31EA~1.QUI/AppData/Local/Temp/msohtmlclip1/01/clip_image006.gif" /></p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Figure 3)</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>Cleaning your nasal spray </strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is important to clean your nasal spray regularly, otherwise it may not work properly.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Remove the dust cap and gently pull off the nozzle.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash the nozzle and dust cap in warm water and then rinse under a runing tap.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not try to unblock the nasal applicator by inserting a pin or other sharp object as this will damage the applicator and cause you not to get the right dose of medicine.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Allow to dry in a warm place.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Push the nozzle back onto the bottle and replace the dust cap.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The spray will need to be re-primed with 2 sprays when first used after leaning.</p><p><strong>If you use more Momate Nasal Spray than you should </strong></p><p>Tell your doctor if you accidentally use more than you were told.</p><p>If you use steroids for a long time or in large amounts they may, rarely, affect some of your hormones. In children this may affect growth and development.</p><p><strong>If you forget to use Momate Nasal Spray </strong></p><p>If you forget to use your nasal spray at the right time, use it as soon as you remember, then carry on as before. Do not take a double dose to make up for a forgotten dose.</p><p><strong>If you stop using Mom ate Nasal Spray </strong></p><p>In some patients Momate Nasal Spray should begin to relieve symptoms 12 hours after the first dose; however full benefit of treatment may not be seen for up to two days. If is very important that you use your nasal spray regularly. Do not stop your treatment even if you feel better unless told to do so by your doctor.</p><p>If you have any further questions on the use of this product, ask your doctor or pharmacist.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>Immediate hypersensitivity (allergc) reactions may occur after use of intranasal mometasone. These reactions may be severe. You should stop taking Momate Nasal Spray and get immediate medical help if you experience symptoms such as:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Swollen face, tongue or pharynx</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; trouble swallowing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; hives</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; wheezing or trouble breathing</p><p>When corticosteroid nasal sprays are used at high doses for long periods of time, side effects may occur due to the drug being absorbed in the body.</p><p><u>Other side effect</u>s</p><p>Most people do not have any problems after using the nasal spray. However, some people, after using intranasal mometasone furoate or other corticosteroids, may find that they suffer from:</p><p><em>Common side effects (mayaffectupto1in 10people):</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sneezing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; nose bleeds [occurred very commonly (may affect more than 1in 10 people) in people with nasal polyps receiving mometasone furoate two sprays in each nostril twice a day]</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; sore nose or throat</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ulcers in the nose</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; respiratory tract infection</p><p>Not <em>known (frequency cannot be estimated from the available data):</em></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; increase in pressure in the eye (glaucoma) and/or cataracts causing visual disturbances.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; damage to the partition in the nose which separates the nostril</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; changes in taste and smell</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; difficulty in breathing and/or wheezing</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; blurred vision</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the bottle label and the outer carton. The expiry date refers to the last day of that month.</p><p>Storebelow30&deg;C.</p><p>Do not freeze . Protect from light. Only open one bottle at a time.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is mometasone furoate. &nbsp;Each spray contains 50 micrograms of mometasone furoate, as the monohydrate.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The other ingredients are glycerol, microcrystaline &nbsp;cellulose and carboxymethylcellulose sodium, sodium citrate, citric acid, polysortiate 80 and benzalkonium chloride</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Nasal Spray is a white to off-white homogenous suspension.
Momate Nasal Spray comes in HDPE bottle and crimped with suitable metered pump and fixed with suitable adaptor.
Each bottle contains 60 and 120 sprays.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers , 22 , Bhulabhai Desai road, Mumbai 400026</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                June 2018
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي بخاخ موميت للأنف على مادة موميتازون فيروات وهو واحد من مجموعة الأدوية المسماة الكورتيكوستيرويدات.</p><p dir="RTL">عندما يتم رش</p><p dir="RTL">يستخدم بخاخ موميت للأنف لعلاج أعراض حمى القش (تسمى أيضاً التهاب الانف التحسسي الموسمي) والتهاب الأنف الحولي في البالغين والأطفال الذين تبلغ اعمارهم 3 سنوات فأكثر. حمى القش، والتي تحدث في أوقات معينة من السنة، هي رد فعل تحسسي ناتج عن تنفس غبار الطلع من الاشجار والأعشاب والحشائش وكذلك الفطور والأبواغ الفطرية. يحدث التهاب الأنف الحولي على مدار العام ويمكن أن تحدث الأعراض نتيجة حساسية تجاه مجموعة متنوعة من الأشياء بما في ذلك عث غبار المنزل وشعر الحيوان ( أو وبر الحيوان) والريش وبعض الأطعمة. يخفف بخاخ موميت للأنف من التورم والتهيج في أنفك، وبالتالي يخفف من العطس والحكة وانسداد الأنف وسيلان الأنف وهي الأعراض التي تسببها حمى القش أو التهاب الأنف الحولي.</p><p dir="RTL"><strong>الزوائد اللحمية الأنفية</strong></p><p dir="RTL">يستخدم بخاخ موميت للأنف لعلاج الزوائد اللحمية الأنفية في البالغين الذين تبلغ أعمارهم 18 عاماً فأكثر. الزوائد الأنفية هي عبارة عن زوائد صغيرة في بطانة الأنف وتؤثر عادة على فتحتي الأنف. يخفف بخاخ موميت من التهاب الأنف، مما يتسبب في تقلص الزوائد اللحمية تدريجياً، وبالتالي يخفف الشعور بانسداد الأنف والذي قد يؤثر على التنفس من خلال الأنف.</p><p dir="RTL">&nbsp;</p><p dir="RTL">مادة موميتازون فيروات داخل الأنف، يمكنها أن تساعد في تخفيف الالتهاب (تورم وتهيج الأنف) والعطس والحكة وانسداد الأنف أوسيلان الأنف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إذا كنت تعاني من حساسية من موميتازون فيروات أو أي من المكونات الأخرى لهذا الدواء (المذكورة في القسم السادس)</p><p dir="RTL">&bull; إذا كنت تعاني من عدوى في أنفك لم يتم علاجها. إن استخدام بخاخ موميت للأنف أثناء وجود عدوى في أنفك لم يتم علاجها، مثل الهيربس، يمكن أن يزيد من حدة العدوى. يجب الانتظار حتى يتم علاج العدوى قبل البدء في استخدام بخاخ الأنف.</p><p dir="RTL">&bull; إذا كنت قد خضعت مؤخراً لعملية في أنفك أو كان لديك إصابة في أنفك. يجب عدم استخدام هذا البخاخ الأنفي حتى يشفى أنفك تماماً.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تحذيرات واحتياطات</strong></p><p dir="RTL">تحدث إلى طبيبك أو الصيدلي قبل استخدام بخاخ موميت للأنف في الحالات الآتية:</p><p dir="RTL">&bull; إذا كنت مصاباً بمرض السل أو أصبت به من قبل.</p><p dir="RTL">&bull; إذا كنت تعاني من أي عدوى أخرى.</p><p dir="RTL">&bull; إذا كنت تتناول أي أدوية كورتيكوستيرويدية أخرى سواء بالفم أو عن طريق الحقن.</p><p dir="RTL">&bull; إذا كنت تعاني من مرض كبدي يعرف بالتليف الكيسي.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>أثناء استعمالك لبخاخ موميت للأنف تواصل مع طبيبك في الحالات الآتية</strong><strong>:</strong></p><p dir="RTL">&bull; إذا كان جهاز المناعة لديك لا يعمل بشكل جيد (إذا كنت تعاني من صعوبة في مكافحة العدوى) وكنت على اتصال مع أي شخص مصاب بالحصبة أو الجديري المائي. يجب تجنب ملامسة أي شخص لديه هذه الانواع من العدوى.</p><p dir="RTL">&bull; إذا كنت تعاني من عدوى في الأنف أو الحلق.</p><p dir="RTL">&bull; إذا كنت تستخدم الدواء لعدة أشهر أو أكثر.</p><p dir="RTL">&bull; إذا كنت تعاني من تهيج مستمر للأنف أو الحلق.</p><p dir="RTL">عندما تستخدم البخاخات الأنفية الكورتيكوستيرويدية بجرعات عالية لفترات طويلة من الزمن، قد تحدث آثار جانبية بسبب امتصاص الدواء في الجسم. إذا شعرت بحكة أو تهيج في عينيك، قد يوصي طبيبك باستخدام أدوية أخرى مع بخاخ موميت للأنف. اتصل بطبيبك إذا كنت تعاني من عدم وضوح في الرؤية أو أي اضطرابات بصرية أخرى.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">عندما تستخدم البخاخات الأنفية الكورتيكوستيرويدية بجرعات عالية لفترات طويلة من الزمن قد تسبب بعض الآثار الجانبية مثل بطء معدل النمو في الأطفال. ينصح بمراقبة طول قامة الأطفال الذين يتلقون علاجاً طويل الأمد بالكورتيكوستيرويدات الأنفية بانتظام، وإذا تم ملاحظة أي تغييرات يجب إخطار الطبيب بذلك.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>استعمال بخاخ موميت للأنف مع الأدوية الأخرى</strong></p><p dir="RTL">اخبر طبيبك أو الصيدلي إذا كنت تتناول أدوية أخرى أو إذا تناولتها مؤخراً أو إذا كنت تنوي تناولها مستقبلاً. إذا كنت تتناول أدوية كورتيكوستيرويدية أخرى لعلاج الحساسية إما عن طريق الفم أو الحقن، قد ينصحك طبيبك بالتوقف عن تناولها بمجرد البدء في استخدام بخاخ موميت للأنف. قد يعاني بعض الناس بمجرد توقفهم عن تناول الكورتيكوستيرويدات عن طريق الفم أو الحقن من بعض الآثار غير المرغوب فيها، مثل آلام المفاصل أو العضلات، والضعف والاكتئاب. قد تعاني أيضاً من أنواع أخرى من الحساسية مثل العيون الدامعة أو ظهور بقع حمراء حاكة في الجلد (الطفح الجلدي). إذا عانيت من أي من هذه الآثار، يجب عليك الاتصال بطبيبك قد تزيد بعض الادوية من تأثير بخاخ موميت للأنف وقد يرغب طبيبك في مراقبتك بعناية إذا كنت تتناول هذه الأدوية (بما في ذلك بعض الادوية الخاصة بفيروس نقص المناعة البشرية: مثل ريتونافير و كوبيسيستات).</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية</strong></p><p dir="RTL">لا تتوفر معلومات كافية حول استخدام بخاخ موميت للانف في النساء الحوامل. من غير المعلوم إفراز موميتازون فيروات في حليب الثدي.</p><p dir="RTL">إذا كنتِ حاملاً أو ترضعين طفلك رضاعة طبيعية أو تعتقدين أنك حاملاً أو تخططين للحمل. استشيري طبيبك قبل تناول هذا الدواء.</p><p dir="RTL"><strong>قيادة السيارات واستخدام الآلات</strong></p><p dir="RTL">لا توجد معلومات معروفة حول تأثير بخاخ موميت للانف على القدرة على قيادة السيارات أو استخدام الآلات.</p><p dir="RTL">يحتوي بخاخ موميت للأنف على مادة كلوريد البنزالكونيوم</p><p dir="RTL">يحتوي بخاخ موميت للانف على مادة كلوريد البنزالكونيوم التي قد تسبب التهاب في الأنف.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">احرص دائماً على استعمال بخاخ موميت للانف تماماً كما أخبرك طبيبك. استشر طبيبك أو الصيدلي إذا كنت غير متأكد. لا تستعمل جرعة أعلى من البخاخ أو تستعمله لمرات أكثر أو لمدة أطول مما حدده طبيبك.</p><p dir="RTL"><strong>علاج حمى القش ( حمى الكلأ) والتهاب الأنف الحولي</strong></p><p dir="RTL"><strong>الاستخدام في البالغين والأطفال الذين تتجاوز أعمارهم 12 عاما </strong></p><p dir="RTL">الجرعة المعتادة هي رشتان في كل فتحة من فتحات الأنف مرة واحدة في اليوم.</p><p dir="RTL">&bull; بمجرد أن تصبح الأعراض تحت السيطرة، قد ينصحك الطبيب بتخفيض الجرعة.</p><p dir="RTL">&bull; إذا لم تبدأ في الشعور بأي تحسن، يجب أن تذهب لطبيبك وقد يخبرك/تخبرك بزيادة الجرعة، مع العلم أن الجرعة اليومية القصوى هي أربع رشات في كل فتحة من فتحات الأنف مرة واحدة في اليوم.</p><p dir="RTL"><strong>الاستخدام في الأطفال الذين تتراوح أعمارهم بين 3 و11 عاماً</strong></p><p dir="RTL"><strong>الجرعة المعتادة هي رشة واحدة في كل فتحة من فتحات الأنف مرة واحدة في اليوم</strong>.</p><p dir="RTL">في بعض المرضى يبدأ بخاخ موميت للأنف في تخفيف الأعراض في غضون 12 ساعة بعد الجرعة الأولى، ومع ذلك قد لا نشعر بالفائدة الكاملة من العلاج في أول يومين. لذلك، يجب عليك الاستمرار في الاستخدام المنتظم لتحقيق الاستفادة الكاملة من العلاج. إذا كنت تعاني أنت أو طفلك بشدة من حمى القش، قد يطلب منك طبيبك البدء في استخدام بخاخ موميت للأنف قبل بضعة أيام من بداية موسم حبوب اللقاح حيث أن ذلك سوف يساعد في منع ظهور أعراض حمى القش.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الزوائد اللحمية الأنفية</strong></p><p dir="RTL"><strong>الاستخدام في البالغين الذين تتجاوز اعمارهم 18 عاماً </strong></p><p dir="RTL">الجرعة المعتادة هي رشتان في كل فتحة من فتحات الأنف مرة واحدة في اليوم.</p><p dir="RTL">&bull; إذا لم يتم السيطرة على الأعراض بعد 5 إلى 6 أسابيع، يمكن زيادة الجرعة إلى رشتين في كل فتحة من فتحات الأنف مرتين يومياً. بمجرد أن تصبح الأعراض تحت السيطرة، قد ينصحك الطبيب بتخفيض الجرعة.</p><p dir="RTL">&bull; إذا لم يتم السيطرة على الأعراض بعد 5 إلى 6 أسابيع من الاستعمال مرتين يومياً، يجب عليك الاتصال بطبيبك.</p><p dir="RTL"><strong>تحضير بخاخ الأنف للاستخدام</strong></p><p dir="RTL">يحتوي بخاخ موميت للأنف على غطاء واقي من الغبار يحمي الفوهة ويحافظ على نظافتها. تذكر أن تنزع هذا الغطاء قبل استخدام البخاخ ثم إعادته بعد الاستخدام.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنت تستخدم البخاخ لأول مرة فأنت بحاجة إلى &quot;تحضير&quot; الزجاجة عن طريق ضخ البخاخ 10 مرات حتى يخرج رذاذ خفيف:</p><p dir="RTL">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رج الزجاجة بلطف.</p><p dir="RTL">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضع السبابة والإصبع الأوسط على جانبي الفوهة وإبهامك تحت الزجاجة. احذر ثقب بخاخ الأنف.</p><p dir="RTL">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وجه الفوهة بعيداً عنك ثم اضغط لأسفل بأصابعك لضخ البخاخ 10 مرات حتى يتم إنتاج رذاذ خفيف.</p><p dir="RTL">إذا كنت قد توقفت عن استخدام البخاخ لمدة 7 أيام أو أكثر فأنت بحاجة إلى &quot;إعادة تحضير&quot; الزجاجة عن طريق ضخ البخاخ مرتين حتى يخرج رذاذ خفيف.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>كيفية استعمال بخاخ موميت للأنف</strong></p><p dir="RTL">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رج الزجاجة بلطف ثم انزع الغطاء الواقي من الغبار. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(الشكل رقم 1)</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="164" height="172" vspace="0" hspace="0" border="0" style="width:164px;height:172px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;&nbsp; &nbsp;</p><p dir="RTL">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نظف أنفك بلطف.</p><p dir="RTL">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اغلق إحدى فتحتي الأنف وضع فوهة البخاخ في الفتحة</p><p dir="RTL">الأخرى كما هو موضح. (الشكل رقم 2) . قم بإمالة رأسك</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="172" height="177" vspace="0" hspace="0" border="0" style="width:172px;height:177px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;</p><p dir="RTL">إلى الأمام قليلاً، مع الاحتفاظ بالزجاجة في وضع مستقيم.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p dir="RTL">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ابداء بالتنفس بهدوء وببطئ من خلال الانف وخلال التنفس اضغط البخاخ للحصول على بخة في الانف</p><p dir="RTL">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أخرج الزفير من فمك كرر الخطوة رقم 4 لاستنشاق بخة ثانية في نفس الفتحة إذا استدعى الأمر.</p><p dir="RTL">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قم بإزالة فوهة البخاخ من فتحة الأنف هذه واخرج الزفير من الفم.</p><p dir="RTL">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كرر الخطوات من 3 إلى 6 للاستعمال في فتحة الأنف الأخر&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">بعد استعمال البخاخ، امسح فوهة البخاخ بعناية باستخدام منديل نظيف</p><p dir="RTL">وقم بإعادة الغطاء الواقي من الغبار. ( الشكل رقم 3)&nbsp;&nbsp;</p><p dir="RTL"><img src="data:image/png;base64,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" alt="" width="172" height="175" vspace="0" hspace="0" border="0" style="width:172px;height:175px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>تنظيف بخاخ الأنف الخاص بك</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; من المهم تنظيف بخاخ الأنف الخاص بك بانتظام، وإلا قد لا يعمل بشكل صحيح.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; انزع الغطاء الواقي من الغبار ثم اسحب الفوهة برفق.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اغسل الفوهة والغطاء الواقي من الغبار بماء دافئ ثم اشطفهما تحت الصنبور.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تحاول فتح جهاز بخاخ الأنف بادخال قلم أو أي شيئ حاد حيث أن ذلك سوف يؤدي إلى تلف البخاخ وبالتالي لن تحصل على الجرعة الصحيحة من الدواء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اترك الغطاء الواقي من الغبار والفوهة في مكان دافئ حتى يجف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ادفع الفوهة مرة أخرى الى الزجاجة وقم بإعادة الغطاء الواقي من الغبار إلى مكانه.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; سوف يحتاج البخاخ إلى التحضير مرة أخرى عن طريق ضخ بختين في أول استخدام له بعد التنظيف.</p><p dir="RTL"><strong>ما يجب فعله عند استعمال بخاخ موميت للأنف اكثر مما ينبغي</strong></p><p dir="RTL">اخبر طبيبك إذا استعملت بخاخ موميت للأنف اكثر مما وصف لك عن طريق الخطأ.</p><p dir="RTL">إذا كنت تستخدم الأدوية الاستيرويدية لفترة طويلة أو بكميات كبيرة فإنها قد تؤثر، نادراً، على بعض الهرمونات. قد يؤثر ذلك على النمو والتطور في الاطفال.</p><p dir="RTL"><strong>ما يجب فعله إذا نسيت استعمال بخاخ موميت للانف</strong></p><p dir="RTL">إذا نسيت استعمال بخاختك في وقتها الصحيح المحدد لها، استعملها بمجرد ان تتذكر، ثم استمر في استعمالها كما كان من قبل. لا تأخذ جرعة مضاعفة لتعويض الجرعة الفائتة.</p><p dir="RTL"><strong>ما يجب فعله إذا توقفت عن استعمال بخاخ موميت للأنف</strong></p><p dir="RTL">في بعض المرضى يبدأ بخاخ موميت للأنف في تخفيف الأعراض في غضون 12 ساعة بعد الجرعة الأولى، ومع ذلك قد لا نشعر بالفائدة الكاملة من العلاج لمدة تصل إلى يومين. من المهم جداً ان تستخدم بخاخة الأنف بانتظام. لا تتوقف عن تناول علاجك حتى لو شعرت بالتحسن ما لم يطلب منك طبيبك القيام بذلك.</p><p dir="RTL"><strong>إذا كان لديك أي أسئلة أخرى حول كيفية استخدام هذا الدواء، اسأل طبيبك أو الصيدلي</strong><strong>.</strong></p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong><strong>&nbsp;</strong></p><p dir="RTL">يمكن ان يتسبب هذا الدواء في حدوث آثار جانبية، شأنه في ذلك شأن جميع الادوية الأخرى، وان كانت لا تصيب كل من يتناوله. قد تحدث تفاعلات فرط الحساسية الفورية بعد استخدام موميتازون داخل الأنف. قد تكون هذه التفاعلات شديدة. يجب التوقف عن استعمال بخاخ موميت للأنف والحصول على مساعدة طبية فورية إذا واجهت أعراضاً مثل:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تورم الوجه أو اللسان أو البلعوم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في البلع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; شرى (أرتيكاريا)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; أزيز ( تنفس بصفير) أو صعوبة في التنفس</p><p dir="RTL">عندما تستخدم البخاخات الانفية الكورتيكوستيرويدية بجرعات عالية لفترات طويلة من الزمن، قد تحدث آثار جانبية بسبب امتصاص الدواء في الجسم.</p><p dir="RTL"><strong>آثار جانبية أخرى</strong></p><p dir="RTL">معظم الناس لا يحدث لهم مشاكل بعد استخدام بخاخ الأنف. ومع ذلك قد يعاني بعض الناس بعد استعمال موميتازون فيروات أو الكورتيكوستيرويدات الأخرى داخل الأنف من:</p><p dir="RTL"><strong>الآثار الجانبية الشائعة ( قد تصيب شخص من بين كل عشرة أشخاص)</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صداع</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عطس</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; نزيف الأنف ] يحدث بشكل شائع جداً (قد يصيب أكثر من شخص من بين كل عشرة أشخاص) في الاشخاص الذين لديهم زوائد لحمية أنفية ويتلقون رشتين من موميتازون فيروات في كل فتحة من فتحات الأنف مرتين يومياً[</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الأنف أو الحلق</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; قرح في الانف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدوى الجهاز التنفسي</p><p dir="RTL"><strong>آثار جانبية غير معروفة ( لا يمكن تقدير معدل تكرارها من خلال البيانات المتاحة):</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة في ضغط العين (الجلوكوما) و / أو إعتام عدسة العين مما يسبب اضطرابات بصرية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تلف الحاجز الأنفي الذي يفصل بين فتحتي الأنف.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تغيرات في حاستي التذوق والشم</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; صعوبة في التنفس و/ أو أزيز (تنفس بصفير)</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; عدم وضوح الرؤية</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; احفظ هذا الدواء بعيداً عن متناول الأطفال.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; لا تستخدم هذا الدواء بعد انتهاء تاريخ الصلاحية الموضح على ملصق الزجاجة والكرتونة الخارجية. ويشير تاريخ انتهاء الصلاحية إلى آخر يوم في ذلك الشهر.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; يحفظ في درجة حرارة لا تزيد عن 30 درجة مئوية.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تجنب تجميد هذا الدواء و احفظه بعيداً عن الضوء.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; افتح زجاجة واحدة فقط في كل مرة.</p><p dir="RTL">يجب عدم التخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الادوية التي لم تعد تستعملها. فسوف تساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعالة هي موميتازون فيروات. تحتوي كل بخه على 50 ميكروجرام من موميتازون فيروات على هيئة موميتازون فيروات مونوهيدرات.</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المكونات الأخرى هي : جليسيرول، وسيليولوز دقيق التبلور، وكربوكسي ميثيل سيليولوز الصوديوم، وسترات الصوديوم، وحمض الستريك، وبولي سوربات 80، وكلوريد البنزالكونيوم.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">بخاخ موميت للأنف هو معلق متجانس أبيض أو أبيض مائل إلى الصفرة.</p><p dir="RTL">يأتي بخاخ موميت للأنف في زجاجة مصنوعة من البولي إيثيلين عالي الكثافة موصولة بمضخة مناسبة ذات عداد ومجهزة بمحول مناسب.</p><p dir="RTL">تحتوي كل زجاجة على 60 و120 رشة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">جلينمارك المحدودة للأدوية، ب/2، غرف ماهالاكسمي، 22، طريق بهولابهاي ديساي، مومباي &nbsp;400026 .</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يونيو 2018
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Momate 50 mcg per actuation Nasal Spray, Suspension 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Composition:      Mometasone Furoate Monohydrate equivalent to Mometasone Furoate …………0.05% w/w
Benzalkonium Chloride BP..........0.02% w/w (as preservative) Excipients………………….q.s  
 
Each spray delivers:  Mometasone Furoate Monohydrate equivalent to Mometasone Furoate ………....50 mcg For the full list of excipients, see Section 6.1. 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Nasal Spray 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Mometasone Furoate Nasal Spray is indicated for use in adults and children 3 years of age and older to treat the symptoms of seasonal allergic or perennial rhinitis.&nbsp;<br />&nbsp;<br />Mometasone Furoate Nasal Spray is indicated for the treatment of nasal polyps in adults 18 years of age and older.&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>After initial priming of the Mometasone Furoate Nasal Spray pump, each actuation delivers approximately 100 mg of mometasone furoate suspension, containing mometasone furoate monohydrate equivalent to 50 micrograms mometasone furoate.<br />Posology<br />Seasonal Allergic or Perennial Rhinitis<br />Adults (including older patients) and children 12 years of age and older: The usual recommended dose is two actuations (50 micrograms/actuation) in each nostril once daily (total dose 200 micrograms). Once symptoms are controlled, dose reduction to one actuation.</p><p>n each nostril (total dose 100 micrograms) may be effective for maintenance. If symptoms are inadequately controlled, the dose may be increased to a maximum daily dose of four actuations in each nostril once daily (total dose 400 micrograms). Dose reduction is recommended following control of symptoms.<br />Children between the ages of 3 and 11 years: The usual recommended dose is one actuation (50 micrograms/actuation) in each nostril once daily (total dose 100 micrograms).<br />Mometasone Furoate Nasal Spray demonstrated a clinically significant onset of action within 12 hours after the first dose in some patients with seasonal allergic rhinitis; however full benefit of treatment may not be achieved in the first 48 hours. Therefore, the patient should continue regular use to achieve full therapeutic benefit.<br />Treatment with Mometasone Furoate Nasal Spray may need to be initiated some days before the expected start of the pollen season in patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis.<br />Nasal Polyposis<br />The usual recommended starting dose for polyposis is two actuations (50 micrograms/actuation) in each nostril once daily (total daily dose of 200 micrograms). If after 5 to 6 weeks symptoms are inadequately controlled, the dose may be increased to a daily dose of two sprays in each nostril twice daily (total daily dose of 400 micrograms). The dose should be titrated to the lowest dose at which effective control of symptoms is maintained. If no improvement in symptoms is seen after 5 to 6 weeks of twice daily administration, the patient should be reevaluated and treatment strategy reconsidered.<br />Efficacy and safety studies of Mometasone Furoate Nasal Spray for the treatment of nasal polyposis were four months in duration.<br />Paediatric population<br />Seasonal Allergic Rhinitis and Perennial Rhinitis<br />The safety and efficacy of Mometasone Furoate Nasal Spray in children under 3 years of age have not been established.<br />Nasal Polyposis<br />The safety and efficacy of Mometasone Furoate Nasal Spray in children and adolescents under 18 years of age have not been established.</p><p>Method of administration<br />Prior to administration of the first dose, shake container well and actuate the pump 10 times (until a uniform spray is obtained). If the pump is not used for 7 days or longer, reprime the pump with 2 actuations until a uniform spray is observed, before next use.<br />Shake container well before each use. The bottle should be discarded after the labeled number of actuations (120 doses).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance mometasone furoate or to any of the excipients listed in section 6.1.
Mometasone Furoate Nasal Spray should not be used in the presence of untreated localised infection involving the nasal mucosa, such as herpes simplex.
Because of the inhibitory effect of corticosteroids on wound healing, patients who have experienced recent nasal surgery or trauma should not use a nasal corticosteroid until healing has occurred.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Immunosuppression<br />Mometasone Furoate Nasal Spray should be used with caution, if at all, in patients with active or quiescent tuberculous infections of the respiratory tract, or in untreated fungal, bacterial, or systemic viral infections.<br />Patients receiving corticosteroids who are potentially immunosuppressed should be warned of the risk of exposure to certain infections (e.g., chickenpox, measles) and of the importance of obtaining medical advice if such exposure occurs.<br />Local Nasal Effects<br />Following 12 months of treatment with Mometasone Furoate Nasal Spray in a study of patients with perennial rhinitis, there was no evidence of atrophy of the nasal mucosa; also mometasone furoate tended to reverse the nasal mucosa closer to a normal histologic phenotype. Nevertheless, patients using Mometasone Furoate Nasal Spray over several months or longer should be examined periodically for possible changes in the nasal mucosa. If localised fungal infection of the nose or pharynx develops, discontinuance of Mometasone Furoate Nasal Spray therapy or appropriate treatment may be required. Persistence of nasopharyngeal irritation may be an indication for discontinuing Mometasone Furoate Nasal Spray.<br />Mometasone Furoate is not recommended in case of nasal septum perforation.<br />In clinical studies, epistaxis occurred at a higher incidence compared to placebo. Epistaxis was generally self-limiting and mild in severity.<br />Mometasone Furoate Nasal Spray contains benzalkonium chloride which may cause nasal irritation.<br />Systemic Effects of Corticosteroids<br />Systemic effects of nasal corticosteroids may occur, particularly at high doses prescribed for prolonged periods. These effects are much less likely to occur than with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations. Potential systemic effects may include Cushing&#39;s syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, cataract, glaucoma and more rarely, a range of psychological or behavioural effects including psychomotor hyperactivity, sleep disorders, anxiety, depression or aggression (particularly in children).<br />Following the use of intranasal corticosteroids, instances of increased intraocular pressure have been reported.<br />Visual disturbance may be reported with systemic and topical (including, intranasal, inhaled and intraocular) corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes of visual disturbances which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.<br />Patients who are transferred from long-term administration of systemically active corticosteroids to Mometasone Furoate Nasal Spray require careful attention. Systemic corticosteroid withdrawal in such patients may result in adrenal insufficiency for a number of months until recovery of HPA axis function. If these patients exhibit signs and symptoms of adrenal insufficiency or symptoms of withdrawal (e.g., joint and/or muscular pain, lassitude, and depression initially) despite relief from nasal symptoms, systemic corticosteroid administration should be resumed and other modes of therapy and appropriate measures instituted. Such transfer may also unmask preexisting allergic conditions, such as allergic conjunctivitis and eczema, previously suppressed by systemic corticosteroid therapy.<br />Treatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used, then<br />additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.<br />Nasal Polyps<br />The safety and efficacy of Mometasone Furoate Nasal Spray has not been studied for use in the treatment of unilateral polyps, polyps associated with cystic fibrosis, or polyps that completely obstruct the nasal cavities.<br />Unilateral polyps that are unusual or irregular in appearance, especially if ulcerating or bleeding, should be further evaluated.<br />Effect on Growth in Paediatric Population<br />It is recommended that the height of children receiving prolonged treatment with nasal corticosteroids is regularly monitored. If growth is slowed, therapy should be reviewed with the aim of reducing the dose of nasal corticosteroid if possible, to the lowest dose at which effective control of symptoms is maintained. In addition, consideration should be given to referring the patient to a paediatric specialist.<br />Non-nasal Symptoms<br />Although Mometasone Furoate Nasal Spray will control the nasal symptoms in most patients, the concomitant use of appropriate additional therapy may provide additional relief of other symptoms, particularly ocular symptoms.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A clinical interaction study was conducted with loratadine. No interactions were observed.<br />Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side-effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Fertility<br />There are no clinical data concerning the effect of mometasone furoate on fertility. Animal studies have shown reproductive toxicity, but no effects on fertility.</p><p>Pregnancy<br />There are no or limited amount of data from the use of mometasone furoate in pregnant women. Studies in animals have shown reproductive toxicity. As with other nasal corticosteroid preparations, Mometasone Furoate Nasal Spray should not be used in pregnancy unless the potential benefit to the mother justifies any potential risk to the mother, foetus or infant. Infants born of mothers who received corticosteroids during pregnancy should be observed carefully for hypoadrenalism.<br />Nursing Mothers<br />It is unknown whether mometasone furoate is excreted in human milk. As with other nasal corticosteroid preparations, a decision must be made whether to discontinue breastfeeding or to discontinue/abstain from Mometasone Furoate Nasal Spray therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile<br />Epistaxis was generally self-limiting and mild in severity, and occurred at a higher incidence compared to placebo (5%), but at a comparable or lower incidence when compared to the active control nasal corticosteroids studied (up to 15%) as reported in clinical studies for allergic rhinitis. The incidence of all other adverse events was comparable with that of placebo. In patients treated for nasal polyposis, the overall incidence of adverse events was similar to that observed for patients with allergic rhinitis.<br />Systemic effects of nasal corticosteroids may occur, particularly when prescribed at high doses for prolonged periods.</p><p>Tabulated list of adverse reactions<br />Treatment related adverse reactions (&ge;1%) reported in clinical trials in patients with allergic rhinitis or nasal polyposis and post-marketing regardless of indication are presented in Table 1. Adverse reactions are listed according to MedDRA primary system organ class. Within each system organ class, adverse reactions are ranked by frequency. Frequencies were defined as follows: Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100). The frequency of post-marketing adverse events are considered as &ldquo;not known (cannot be estimated from the available data)&rdquo;.</p><p>&nbsp;</p><p>&nbsp;</p><p>Paediatric population<br />In the paediatric population, the incidence of recorded adverse events in clinical studies, e.g., epistaxis (6%), headache (3%), nasal irritation (2%) and sneezing (2%) was comparable to placebo.<br />Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptoms<br />Inhalation or oral administration of excessive doses of corticosteroids may lead to suppression of HPA axis function.<br />Management<br />Because the systemic bioavailability of mometasone furoate nasal spray is &lt;1%, overdose is unlikely to require any therapy other than observation, followed by initiation of the appropriate prescribed dosage.<br /><img src="data:image/png;base64,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" alt="" width="600" height="398" vspace="0" hspace="0" border="0" style="width:600px;height:398px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>Paediatric population<br />In the paediatric population, the incidence of recorded adverse events in clinical studies, e.g., epistaxis (6%), headache (3%), nasal irritation (2%) and sneezing (2%) was comparable to placebo.</p><p>&nbsp;</p><p>Reporting of suspected adverse reactions<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Decongestants and Other Nasal Preparations for Topical Use Corticosteroids<br />ATC code: R01A D09<br />Mechanism of action<br />Mometasone furoate is a topical glucocorticosteroid with local anti-inflammatory properties at doses that are not systemically active.<br />It is likely that much of the mechanism for the anti-allergic and anti-inflammatory effects of mometasone furoate lies in its ability to inhibit the release of mediators of allergic reactions. Mometasone furoate significantly inhibits the release of leukotrienes from leucocytes of allergic patients. In cell culture, mometasone furoate demonstrated high potency in inhibition of synthesis and release of IL1, IL5, IL6 and TNF&alpha;; it is also a potent inhibitor of leukotriene<br />production. In addition, it is an extremely potent inhibitor of the production of the Th2 cytokines, IL4 and IL5, from human CD4+ T-cells.<br />Pharmacodynamic effects<br />In studies utilising nasal antigen challenge, Mometasone Furoate Nasal Spray has shown anti-inflammatory activity in both the early- and late-phase allergic responses. This has been demonstrated by decreases (vs placebo) in histamine and eosinophil activity and reductions (vs baseline) in eosinophils, neutrophils, and epithelial cell adhesion proteins.<br />In 28% of the patients with seasonal allergic rhinitis, Mometasone Furoate Nasal Spray demonstrated a clinically significant onset of action within 12 hours after the first dose. The median (50%) onset time of relief was 35.9 hours.<br />Paediatric population<br />In a placebo-controlled clinical trial in which paediatric patients (n=49/group) were administered Mometasone Furoate Nasal Spray 100 micrograms daily for one year, no reduction in growth velocity was observed.<br />There are limited data available on the safety and efficacy of Mometasone Furoate Nasal Spray in the paediatric population aged 3 to 5 years, and an appropriate dosage range cannot be established. In a study involving 48 children aged 3 to 5 years treated with intranasal mometasone furoate 50, 100 or 200 &mu;g/day for 14 days, there was no significant differences from placebo in the mean change in plasma cortisol level in response to the tetracosactrin stimulation test.<br />The European Medicines Agency has waived the obligation to submit the results of studies with Mometasone Furoate Nasal Spray and associated names in all subsets of the paediatric population in seasonal and perennial allergic rhinitis.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Mometasone furoate, administered as an aqueous nasal spray, has a systemic bioavailability of &lt;1% in plasma, using a sensitive assay with a lower quantitation limit of 0.25 pg/ml.<br />Distribution<br />Not applicable as mometasone is poorly absorbed via the nasal route.<br />Biotransformation<br />The small amount that may be swallowed and absorbed undergoes extensive first-pass hepatic metabolism.<br />Elimination<br />Absorbed mometasone furoate is extensively metabolized and the metabolites are excreted in urine and bile.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No toxicological effects unique to mometasone furoate exposure were demonstrated. All observed effects are typical of this class of compounds and are related to exaggerated pharmacologic effects of glucocorticoids.<br />Preclinical studies demonstrate that mometasone furoate is devoid of androgenic, anti-androgenic, estrogenic or anti-estrogenic activity but, like other glucocorticoids, it exhibits some anti-uterotrophic activity and delays vaginal opening in animal models at high oral doses of 56 mg/kg/day and 280 mg/kg/day.<br />Like other glucocorticoids, mometasone furoate showed a clastogenic potential in vitro at high concentrations. However, no mutagenic effects can be expected at therapeutically relevant doses.<br />In studies of reproductive function, subcutaneous mometasone furoate, at 15 micrograms/kg prolonged gestation and prolonged and difficult labour occurred with a reduction in offspring survival and body weight or body weight gain. There was no effect on fertility.<br />Like other glucocorticoids, mometasone furoate is a teratogen in rodents and rabbits. Effects noted were umbilical hernia in rats, cleft palate in mice and gallbladder agenesis, umbilical hernia, and flexed front paws in rabbits. There were also reductions in maternal body weight gains, effects on foetal growth (lower foetal body weight and/or delayed ossification) in rats, rabbits and mice, and reduced offspring survival in mice.<br />The carcinogenicity potential of inhaled mometasone furoate (aerosol with CFC propellant and surfactant) at concentrations of 0.25 to 2.0 micrograms/L was investigated in 24-month studies in mice and rats. Typical glucocorticoid-related effects, including several non-neoplastic lesions, were observed. No statistically significant dose-response relationship was detected for any of the tumour types.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Microcrystalline cellulose and carboxymethylcellulose sodium (Avicel RC591) BP<br />Glycerol BP<br />Citric acid monohydrate BP<br />Sodium citrate BP<br />Polysorbate 80 (Super refined Tween 80) BP<br />Benzalkonium Chloride BP<br />Water for injection BP</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months/2 years
Use within 24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Keep this medicine out of reach of children.<br />Store below 30&deg;C.<br />Do not freeze. Protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Nasal suspension filled in HDPE bottle and crimped with suitable metered pump and fixed<br />with suitable adaptor</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Any unused product or waste material should be disposed of in accordance with local<br />requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers,
22, Bhulabhai Desai road, Mumbai – 400 026
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                June-2018
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>